Novavax Announces Purchase Agreement With European Commission For Up To 200 Million COVID-19 Vaccine Doses
Novavax, Inc. (Nasdaq: NVAX) announced today that it has reached an agreement with the European Commission for the purchase of up to 200 million doses of the company’s COVID-19 vaccine candidate NVX-CoV2373. The agreement stipulates an initial 100-million dose purchase with an option to purchase 100 million more through 2023. “As new coronavirus variants are […]
MustGrow Biologics Enters Exclusive Arrangement With Sumitomo Corp
It appears that MustGrow Biologics (CSE: MGRO) is on the right path with its proprietary mustard-based formulations. The company this morning, after being halted from trading yesterday, announced that it has entered into an exclusive evaluation and option agreement with Sumitomo Corporation (TYO: 8053) (OTC: SSUMY). The exclusive arrangement will see the evaluation of MustGrow’s […]
Empower Clinics Wraps Up Kai Medical Laboratory Expansion
Empower Clinics Inc. (CSE: CBDT) shared this morning the completion of the expansion of its subsidiary Kai Medical Laboratory. The company previously announced that the expansion will see the lab’s total operation reportedly triple in size. The expansion not only increased the laboratory’s capacity but also brought new services such as dried blood spot card-based […]
Heritage Cannabis Sees Sharples Step Down As CEO, Appointed Chair
Heritage Cannabis (CSE: CANN) has seen a management shakeup occur this morning. The company has seen the resignation of directors from the firms board, as well as the departure of Clint Sharples as the firms Chief Executive Officer. More specifically, Sharples will be transitioning from his role of CEO, where he has served for a […]
Datametrex Enters Second Round Of Process For Potential $40 Million Contract
It appears that Datametrex AI (TSXV: DM) is well on its way to potentially being awarded a major contract in Canada. The company this morning revealed it is currently in the process of bidding on an artificial contract in Canada, the value of which has been pegged at $40.0 million. Details on the potential contract […]
Fire & Flower Eyes Acquiring Wikileaf Assets For $7.5 Million, Bares Online Dispensary Strategy
Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Hifyre Inc. announced today the definitive asset purchase agreement to acquire certain assets from subsidiaries of online cannabis platform Wikileaf Technologies Inc. (CSE: WIKI). The company said this move is part of its digital strategy to enhance its online retail platform. The total consideration […]
InsuraGuest Appoints Hospitality Industry Veteran Reed Wright As President
InsuraGuest Technologies (TSXV: ISGI) has bolstered its management team. The company this morning announced the appointment of tech and hospitality industry veteran Reed Wright to the role of President for the firm. Equipped with a BA in Communications and Business from Brigham Young University, Wright is an industry veteran within both the tech and hospitality […]
KetamineOne Brings Scent-Enabled Virtual Reality To Psychedelic Therapy
KetamineOne Capital (NEO: MEDI) appears to be taking a rather novel approach to psychedelic treatments. The firm this morning revealed that it has signed an exclusive agreement to bring virtual reality to the treatment options the firm provides, with the tech further enhanced by providing an “olfactory-enabled” experience. The agreement itself is with that of […]
Hut 8 Mining Sees Production Increase To 9.7 Bitcoin Per Day
Hut 8 Mining Corp (NASDAQ: HUT) (TSX: HUT) this morning issued a production update for the month of July. The company, as previously guided, has seen its monthly production increase to 9.7 bitcoin per day. The production rate translates to 300 bitcoin mined during the month of July. The significantly improved production on a month […]
Royal Caribbean Cruises: Analysts Expect Q4 Loss Per Share Of $4.39
Royal Caribbean Cruises (NYSE: RCL) will be reporting their second quarter financial results before the market opens on August 4. Analysts have a consensus $92.75 12-month price target on the company, via a total of 18 analysts, with 3 analysts having strong buy ratings, 5 analysts having buy ratings, 7 have hold ratings and 3 […]